Biomanufacturing is the use of advanced manufacturing approaches to produce the next generation of healthcare products, such as cell therapies, engineered tissues, pharmaceuticals, and medical devices, as well as drug discovery and testing platforms.



Biomanufacturing as an industry is experiencing explosive growth within the United States. Of note, private companies have increasingly focused on biomanufacturing products for the large and rapidly expanding regenerative medicine market (23.7% CAGR, $50B global market by 2021). Wisconsin’s research universities are internationally recognized leaders in areas critical for developing biomanufacturing technologies (engineering, life sciences, medicine, veterinary, and technology transfer) and have a proven track record in successfully spinning out biomanufacturing companies, which have attracted an influx of larger industry partners. In addition, the state of Wisconsin is home to 1,600 companies in the biohealth space and 43,000 jobs (excluding healthcare institutions). Wisconsin’s inordinately large life science industry relative to its size, well established supply chain, and proximity to medical device and pharma hubs, make it an ideal Midwest epicenter for biomanufacturing innovation.